Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$25.5 - $31.51 $1,504 - $1,859
59 Added 0.17%
35,637 $1.02 Million
Q1 2024

Apr 16, 2024

BUY
$27.7 - $35.48 $41,965 - $53,752
1,515 Added 4.45%
35,578 $1.04 Million
Q4 2023

Jan 24, 2024

SELL
$26.32 - $34.31 $13,739 - $17,909
-522 Reduced 1.51%
34,063 $1.15 Million
Q3 2023

Oct 19, 2023

SELL
$30.68 - $40.09 $18,592 - $24,294
-606 Reduced 1.72%
34,585 $1.06 Million
Q2 2023

Jul 24, 2023

BUY
$36.12 - $47.5 $28,209 - $37,097
781 Added 2.27%
35,191 $1.41 Million
Q1 2023

Apr 28, 2023

BUY
$35.53 - $43.38 $15,988 - $19,521
450 Added 1.33%
34,410 $1.4 Million
Q4 2022

Jan 26, 2023

BUY
$38.19 - $57.45 $36,586 - $55,037
958 Added 2.9%
33,960 $0
Q3 2022

Oct 27, 2022

BUY
$51.24 - $58.89 $40,582 - $46,640
792 Added 2.46%
33,002 $1.76 Million
Q2 2022

Jul 19, 2022

BUY
$51.49 - $81.64 $73,064 - $115,847
1,419 Added 4.61%
32,210 $1.88 Million
Q1 2022

Apr 27, 2022

BUY
$60.03 - $76.49 $41,360 - $52,701
689 Added 2.29%
30,791 $2.35 Million
Q4 2021

Jan 24, 2022

BUY
$47.97 - $62.21 $687,554 - $891,655
14,333 Added 90.89%
30,102 $1.81 Million
Q3 2021

Oct 15, 2021

BUY
$54.64 - $61.3 $42,455 - $47,630
777 Added 5.18%
15,769 $883,000
Q2 2021

Jul 16, 2021

BUY
$59.18 - $69.99 $49,237 - $58,231
832 Added 5.88%
14,992 $910,000
Q1 2021

Apr 19, 2021

BUY
$59.31 - $78.82 $839,829 - $1.12 Million
14,160 New
14,160 $992,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Campbell Newman Asset Management Inc Portfolio

Follow Campbell Newman Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell Newman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Campbell Newman Asset Management Inc with notifications on news.